Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-01 09:40 | Swedish | 10.1 KB | |||
| 2025-09-30 15:00 |
Change in number of shares and votes in Alligator Bioscience AB
|
English | 54.8 KB | ||
| 2025-09-30 15:00 |
Ändring av antalet aktier och röster i Alligator Bioscience AB
|
Swedish | 55.3 KB | ||
| 2025-09-29 20:19 | Swedish | 11.1 KB | |||
| 2025-09-26 11:08 | Swedish | 11.1 KB | |||
| 2025-09-17 15:00 |
Alligator Bioscience AB announces final outcome of exercise of warrants series …
|
English | 65.7 KB | ||
| 2025-09-17 15:00 |
Alligator Bioscience AB meddelar slutligt utfall för nyttjandet av teckningsopt…
|
Swedish | 65.6 KB | ||
| 2025-09-16 11:45 |
Alligator Bioscience AB announces preliminary outcome of exercise of warrants s…
|
English | 65.5 KB | ||
| 2025-09-16 11:45 |
Alligator Bioscience AB meddelar preliminärt utfall för nyttjandet av tecknings…
|
Swedish | 65.1 KB | ||
| 2025-09-11 08:30 |
Sista dag för handel med teckningsoptioner serie TO 13 i Alligator Bioscience ä…
|
Swedish | 67.7 KB | ||
| 2025-09-11 08:30 |
Last day of trading in warrants series TO 13 in Alligator Bioscience is 11 Sept…
|
English | 67.2 KB | ||
| 2025-09-08 22:10 |
Alligator Bioscience has renegotiated the outstanding loan from Fenja Capital a…
|
English | 71.6 KB | ||
| 2025-09-08 22:10 |
Alligator Bioscience har omförhandlat det utestående lånet från Fenja Capital o…
|
Swedish | 71.7 KB | ||
| 2025-08-27 21:00 |
Exercise price determined for the exercise of warrants series TO 13 in Alligato…
|
English | 72.6 KB | ||
| 2025-08-27 21:00 |
Teckningskurs fastställd för nyttjandet av teckningsoptioner serie TO 13 i Alli…
|
Swedish | 72.8 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
